Medicare Enrolled

Dr. Zhora Oganisyan, MD

Neurology · Bradenton, FL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
7005 CORTEZ RD W, Bradenton, FL 34210
9414654800
In practice since 2012 (13 years)
NPI: 1508126624 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Oganisyan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Oganisyan? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Oganisyan

Dr. Zhora Oganisyan is a neurology specialist in Bradenton, FL, with 13 years of NPI registration. Based on federal Medicare data, Dr. Oganisyan performed 802 Medicare services across 663 unique beneficiaries.

Between the years covered by Open Payments, Dr. Oganisyan received a total of $17,677 from 77 pharmaceutical and/or device companies across 884 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Oganisyan is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 13 years in practice ▲ Top 36% volume in FL $17,677 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 132623 Clear January 31, 2027
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary

Medicare Utilization ↗
802
Medicare services
Top 36% in FL for neurology
663
Unique beneficiaries
$100
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~62 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Initial hospital admission, high complexity 199 $135 $435
Hospital follow-up visit, moderate complexity 184 $62 $153
New patient office visit, complex (60-74 min) 78 $151 $443
Office visit, established patient (30-39 min) 73 $90 $225
Measurement of brain wave activity (eeg), awake and drowsy 66 $43 $178
Office visit, established patient, complex (40-54 min) 62 $135 $303
Needle measurement of electrical activity in arm or leg muscles, complete study 43 $73 $279
Hospital follow-up visit, high complexity 29 $89 $220
Hospital follow-up visit, low complexity 26 $40 $86
Measurement of brain wave activity with video (veeg), 61-84 hours with review and report by health care professional 15 $254 $1,027
Measurement of brain wave activity (eeg), in coma or asleep 15 $44 $175
Nerve conduction, 7-8 studies 12 $116 $592
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$17,677
Total received (2018-2024)
Avg $2,525/year across 7 years
Top 18% in FL for neurology
77
Companies
884
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$17,657 (99.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$19 (0.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,927
2023
$3,747
2022
$3,649
2021
$2,635
2020
$1,226
2019
$1,953
2018
$1,539

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$1,578
Novartis Pharmaceuticals Corporation
$1,081
Teva Pharmaceuticals USA, Inc.
$859
SK Life Science, Inc.
$713
JAZZ PHARMACEUTICALS INC.
$662
GENZYME CORPORATION
$653
Allergan, Inc.
$637
Amgen Inc.
$635
Biogen, Inc.
$554
LivaNova USA, Inc.
$550
UCB, Inc.
$524
Celgene Corporation
$491
PFIZER INC.
$452
Lilly USA, LLC
$437
Eisai Inc.
$424
Alexion Pharmaceuticals, Inc.
$406
Avanir Pharmaceuticals, Inc.
$381
GE HEALTHCARE
$377
AbbVie Inc.
$375
EMD Serono, Inc.
$364
Abbott Laboratories
$353
Sunovion Pharmaceuticals Inc.
$318
Allergan Inc.
$313
Genentech USA, Inc.
$294
GE HealthCare
$267
Boston Scientific Corporation
$233
Lundbeck LLC
$222
ARGENX US, INC.
$193
ACADIA Pharmaceuticals Inc
$179
Neurocrine Biosciences, Inc.
$177
Otsuka America Pharmaceutical, Inc.
$170
Jazz Pharmaceuticals Inc.
$157
Merz Pharmaceuticals, LLC
$141
Greenwich Biosciences, Inc.
$134
CSL Behring
$130
Amneal Pharmaceuticals LLC
$123
Neurelis, Inc.
$117
Grifols USA, LLC
$115
Silk Road Medical, Inc.
$113
Harmony Biosciences LLC
$113
Vanda Pharmaceuticals Inc.
$108
Janssen Pharmaceuticals, Inc
$107
Alnylam Pharmaceuticals Inc.
$90
Acorda Therapeutics, Inc
$90
Nevro Corp.
$75
Horizon Therapeutics plc
$75
Supernus Pharmaceuticals, Inc.
$71
Biohaven Pharmaceutical Holding Company Ltd.
$70
Kyowa Kirin, Inc.
$69
Biohaven Pharmaceuticals, Inc.
$66
Sumitomo Pharma America, Inc.
$65
EISAI INC.
$63
GE Healthcare
$62
HARMONY BIOSCIENCES LLC
$61
Adamas Pharmaceuticals, Inc.
$56
E.R. Squibb & Sons, L.L.C.
$50
Xeris Pharmaceuticals, Inc.
$44
MITSUBISHI TANABE PHARMA AMERICA, INC.
$42
AbbVie, Inc.
$38
UPSHER-SMITH LABORATORIES LLC
$29
MDD US Operations, LLC
$26
Axsome Therapeutics, Inc.
$25
SANOFI-AVENTIS U.S. LLC
$25
CATALYST PHARMACEUTICALS, INC.
$25
Banner Life Sciences, LLC
$25
Impax Laboratories, Inc.
$24
Corium, LLC
$22
IDORSIA PHARMACEUTICALS US INC
$22
GRT US Holding, Inc.
$20
Bayer HealthCare Pharmaceuticals Inc.
$20
Akcea Therapeutics, Inc.
$17
Medacta USA, Inc.
$16
Mitsubishi Tanabe Pharma America, Inc.
$15
US WorldMeds, LLC
$15
Zogenix Inc.
$15
AstraZeneca Pharmaceuticals LP
$11
Egalet US Inc
$11
Top 3 companies account for 19.9% of total payments
Associated products mentioned in payments ›
ADUHELM · AFINITOR · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · BRILINTA · Betaseron · Briviact · COMIRNATY · COPAXONE · DUOPA · Duopa · EMGALITY · ENROUTE Transcarotid Neuroprotection System · EPIDIOLEX · Epidiolex · FIRDAPSE · Fintepla · Fycompa · GILENYA · GOCOVRI · Gamunex-C · General - DBS · HETLIOZ · Hizentra · INBRIJA · INFINITY · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KEVEYIS · KISUNLA · KYNMOBI · LEMTRADA · LUMIZYME · Leqembi · MAVENCLAD · MAYZENT · Mavenclad · MectaLif · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONPATTRO · Ocrevus · Omnia · Ongentys · PANZYGA · PAXLOVID · PROCLAIM · Ponvory · QULIPTA · QUVIVIQ · Qutenza · RADICAVA · REXULTI · RYTARY · Radicava · Rebif · SOLIRIS · SPINRAZA · SPRIX · SUNOSI · Senza · Soliris · Sunosi · TECFIDERA · TEGSEDI · TOSYMRA · TROKENDI XR · TYSABRI · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS - Sentiva · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VRAYLAR · VUMERITY · VYALEV · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAKIX · WATCHMAN · Wakix · XCOPRI · XYREM · XYWAV · Xeomin · Xyrem · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $2,204 per 100 Medicare services performed
Looking for a neurology specialist in Bradenton?
Compare neurologists in the Bradenton area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
55
Per 100K population
13.2
County median income
$75,792
Nearest hospital
SUNCOAST BEHAVIORAL HEALTH CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Oganisyan is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 18% of FL peers.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Oganisyan experienced with initial hospital admission, high complexity?
Based on Medicare claims data, Dr. Oganisyan performed 199 initial hospital admission, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Oganisyan receive payments from pharmaceutical companies?
Yes. Dr. Oganisyan received a total of $17,677 from 77 companies across 884 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Oganisyan's costs compare to other neurologists in Bradenton?
Dr. Oganisyan's average Medicare payment per service is $100. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Oganisyan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →